ESC 2024: Insights into RNA as therapeutic target and tool
On the last day of the European Society of Cardiology (ESC) 2024 Congress (2 September), a panel discussed the therapeutic…
On the last day of the European Society of Cardiology (ESC) 2024 Congress (2 September), a panel discussed the therapeutic…
The results of two subanalyses of the PACMAN-AMI trial were presented on the final day (2 September) of the European…
Taipei-based biotech Acepodia announced yesterday (3 September) that it has agreed to a collaboration with Pfizer Ignite, a subsidiary of…
For several decades, a heated debate on the continually rising price of medicines in the US has centred on pharmacy…
Arcus Biosciences has announced a loan from financer Hercules Capital valued at as much as $250m, contingent on the advancement…
The European Commission (EC) has approved a Type II extension for Johnson and Johnson (J&J)’s immunotherapy Rybrevant (amivantamab), which was…
Emergent BioSolutions announced that it has finalised the sale of its Baltimore-Camden manufacturing site to the Taiwanese firm Bora Pharmaceuticals.…
The US Food and Drug Administration (FDA) has granted an orphan drug designation and fast track designation to ReAlta Life…
Sound Pharmaceuticals wishes to maintain its relationship with WuXi AppTec for manufacturing its lead Meniere’s disease drug SPI-1005, amidst increasing…
Gilead Sciences’ Livdelzi (seladelpar) has received an accelerated approval from the US Food and Drug Administration (FDA) to treat primary…